Anal incontinence incidence is high in patients with obesity prior to bariatric surgery: Prevalence, risks-factors.


Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 10 07 2022
revised: 04 10 2022
accepted: 25 10 2022
pubmed: 3 12 2022
medline: 8 3 2023
entrez: 2 12 2022
Statut: ppublish

Résumé

Anal incontinence (AI) prevalence in general population is estimate to range from 1.4 to 19.5% (Wexner ≥ 1). Obesity could be an AI risk factor. However, AI prevalence in patients with obesity is not clearly established. The main objective of this study was to assess the prevalence of AI in patients with extreme obesity prior to bariatric surgery and to identify specific AI risk factors in this subset of patients. A cross-sectional study, in a tertiary referral center in obesity was performed during one year. Patients who presented criteria for bariatric surgery (BMI>40 or BMI > 35 with co-morbidities) were asked to fill in preoperative self-questionnaires. A Wexner score ≥ 3 was used to define AI to identified patients who had a clinic impact of AI, by frequency of symptoms or alteration of quality of life. Two hundred and fifty patients were included. Corresponded to, 196 women (78.4%) and 54 men (21.6%). Median BMI was 44.53kg/m AI is frequently observed in patients with extreme obesity scheduled for bariatric surgery and should be routinely evaluated. Modifiable risk factors as constipation should be manage before surgery as well as the specific management of AI, to prevent AI exacerbation after surgery. The choice of bariatric surgical procedure should be discussed and evaluated for the treatment of patients with obesity and AI. Moderate.

Identifiants

pubmed: 36460604
pii: S1166-7087(22)00475-4
doi: 10.1016/j.purol.2022.10.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-216

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Auteurs

A Postillon (A)

Department of Gastrointestinal, Metabolic and Surgical Oncology, University Hospital of Nancy, rue du Morvan, Vandoeuvre-les-Nancy, France. Electronic address: agathe.postillon@gmail.com.

C Buisset (C)

Department of Digestive, Endocrine and Metabolic Surgery, UNEOS groupe hospitalier associatif, hôpital Robert-Schuman, rue du Champ Montoy, Metz, France.

A Parvanescu (A)

Department of Digestive Surgery, hôpital Saint-Joseph, rue Raymond-Losserand, Paris, France.

F Bihain (F)

Department of Gastrointestinal, Metabolic and Surgical Oncology, University Hospital of Nancy, rue du Morvan, Vandoeuvre-les-Nancy, France.

D Quilliot (D)

Department of Diabetology, Endocrinology and Nutrition, University Hospital of Nancy, rue du Morvan, Vandoeuvre-les-Nancy, France.

L Brunaud (L)

Department of Gastrointestinal, Metabolic and Surgical Oncology, University Hospital of Nancy, rue du Morvan, Vandoeuvre-les-Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH